The Global Genotyping Market accounted for USD 6120 million in 2015 and expected to register healthy growth during the forecast period (2018–2023) at a CAGR of 22.5%.
Genotyping services help to understand the genetic structure of any living organisms such as humans, animals, plants, and microorganisms. Human genotyping provides data related to the genetic history of an individual; microorganism genotyping provide aid in research and development of bacterial and viral diseases. The increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, technological advancement, and surge in demand for personalized medication are expected to drive the growth of the market. Moreover, decreasing prices of genotyping services due to intense competition is contributing to the growth of the market. According to the Centers for Disease Control and Prevention (CDC), Genetic disorders are constantly increasing, and in the US more than 120000 babies are born with congenital disabilities, which are caused by genetic changes.
The uncertainty related to reimbursement and lack of skilled people may hamper the growth of the market during the assessment period.
Segmentation
The Global Genotyping Market has been segmented on the basis of technology, product, application, and end-user.
On the basis of technology, the market has been classified as sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.
The product segment has been divided into reagents and kits, instruments, and services.
The application segment has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.
The market, by end-user, has been segmented into hospitals, diagnostic centers, academic institutes, and research and development centers.
Key Players
Some of the key players in the global genotyping market are QIAGEN, Affymetrix, Inc., Illumina, Inc, Thermo Fisher Scientific, Inc., General Electric Company, Agilent Technologies, Inc., Fluidigm Corporation, Sequenom, F. Hoffmann-La Roche Ltd, and Beckman Coulter, Inc.
Global Genotyping Market, by Technology
Global Genotyping Market, by Product
Global Genotyping Market, by Application
Global Genotyping Market, by End User
Global Genotyping Market, by Region